Home - RESEARCH & DEVELOPMENT - Translational Medicine Research Center
Translational Medicine Research Center
  • Clinical Development
  • Translational Medicine Research Center
  • Pipeline
  • CStone Suzhou Translational Medicine Research Center (TMRC) is a cutting edge clinical research institution built according to international standards. The primary goal of the center is to accelerate clinical development through the discovery and validation of predictive biomarkers, in order to bring the right therapies to the right patients in China. With the establishment of the Suzhou TMRC, CStone has solidified its global strategic roadmap. We expect to have several Class I innovative anti-cancer drugs at different phases of clinical development by 2020.

    THREE MAIN GOALS
    WORLD-CLASS RESEARCH, COLLABORATION, AND DEVELOPMENT PLATFORM

    TRANSLATIONAL MEDICINE

    Pre-clinical Preclinical Discoveries Validate Resistance Mechanism Clinical

    Use preclinical discoveries to guide patient selection and monitor treatment response in clinical trials; use clinical findings to guide preclinical discovery of drug resistance mechanisms.

    BIOMARKERS

    Increase the success rate of clinical trials by three times 26% With Biomarkers 8% Without Biomarkers

    Facilitate the development of precision medicine by accurate prediction of treatment response.